APP and Alzheimer disease: Mutations in ADAM10 (Q170H and R181G) have been identified in seven late-onset AD families [14] and attenuate α-secretase activity of ADAM10 and shift APP processing toward β-secretase-mediated cleavage, enhancing Aβ plaque formation and reactive gliosis [15].